Jeffrey Stein
2018
In 2018, Jeffrey Stein earned a total compensation of $1.4M as President and Chief Executive Officer at Cidara Therapeutics, a 25% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $201,400 |
|---|---|
| Option Awards | $661,337 |
| Salary | $501,000 |
| Total | $1,363,737 |
Stein received $661.3K in option awards, accounting for 48% of the total pay in 2018.
Stein also received $201.4K in non-equity incentive plan and $501K in salary.
Rankings
In 2018, Jeffrey Stein's compensation ranked 7,626th out of 14,244 executives tracked by ExecPay. In other words, Stein earned more than 46.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,626 out of 14,244 | 47th |
Division Manufacturing | 2,964 out of 5,765 | 49th |
Major group Chemicals And Allied Products | 1,112 out of 2,128 | 48th |
Industry group Drugs | 941 out of 1,817 | 48th |
Industry Biological Products, Except Diagnostic Substances | 175 out of 339 | 48th |
Source: SEC filing on April 26, 2019.
Stein's colleagues
We found three more compensation records of executives who worked with Jeffrey Stein at Cidara Therapeutics in 2018.
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019